KYTHERA BIOPHARMACEUTICALS
KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California. KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.
KYTHERA BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care
Founded:
2005-08-01
Address:
Calabasas, California, United States
Country:
United States
Website Url:
http://www.kytherabiopharma.com
Total Employee:
101+
Status:
Active
Contact:
(818) 587-4500
Email Addresses:
[email protected]
Total Funding:
223.4 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Liquid Web
Similar Organizations
Rosetta Genomics
Rosetta Genomics discovers, develops and commercializes diagnostic tests for personalized medicine.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Prospect Venture Partners
Prospect Venture Partners investment in Series D - Kythera Biopharmaceuticals
Versant Ventures
Versant Ventures investment in Series D - Kythera Biopharmaceuticals
Invus
Invus investment in Series D - Kythera Biopharmaceuticals
Latham & Watkins
Latham & Watkins investment in Series D - Kythera Biopharmaceuticals
BB&T
BB&T investment in Series D - Kythera Biopharmaceuticals
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series D - Kythera Biopharmaceuticals
Foley Ventures
Foley Ventures investment in Series D - Kythera Biopharmaceuticals
ARCH Venture Partners
ARCH Venture Partners investment in Series D - Kythera Biopharmaceuticals
Versant Ventures
Versant Ventures investment in Series C - Kythera Biopharmaceuticals
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series C - Kythera Biopharmaceuticals
Official Site Inspections
http://www.kytherabiopharma.com
Unable to get host informations!!!
More informations about "Kythera Biopharmaceuticals"
Kythera Biopharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number (818) 587-4500 KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was …See details»
KYTHERA Biopharmaceuticals - VentureRadar
KYTHERA has an innovative pipeline, with its lead program in adipolysis (ATX-101) projected to start US Phase III trials late in 2011 or early 2012. The company also has active research …See details»
Kythera Biopharmaceuticals - PitchBook
Kythera Biopharmaceuticals General Information Description. Operator of a clinical-stage biopharmaceutical company headquartered in Calabasas, California. The company focuses on …See details»
Kythera Biopharmaceuticals - Ownership and Business Overview
Oct 1, 2015 www.kytherabiopharma.com. Profile Investors (1) Analytics Kythera Biopharmaceuticals, Inc. is a company focused on the discovery, development and …See details»
KYTHERA Biopharmaceuticals, Inc. - Dun & Bradstreet
Company Description: KYTHERA Biopharmaceuticals hopes to one day help patients want to take (its product) on the chin. A maker of pharmaceutical products for the aesthetics market, …See details»
Kythera Biopharmaceuticals, Inc - University of …
CNSI. 570 Westwood Plaza Building 114 | Mail Code: 722710 Los Angeles, CA 90095 Tel: (310) 267-4838 Fax: (310) 267-4918See details»
Kythera Biopharmaceuticals LLC - Company Profile and News
Company profile page for Kythera Biopharmaceuticals LLC including stock price, company news, executives, board members, and contact informationSee details»
Allergan PLC Completes Acquisition of… | American Med Spa …
Oct 12, 2015 Allergan PLC (NYSE:AGN) had two major announcements made public on Thursday. The first was the successful completion of the company’s acquisition of Kythera …See details»
Allergan to buy Kythera Biopharmaceuticals for $2.1bn
Jun 17, 2015 2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s …See details»
Allergan Successfully Completes Kythera Acquisition; Adds Game …
Oct 5, 2015 Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition of KytheraSee details»
Allergan Successfully Completes Kythera Acquisition - Pharmacy …
Oct 1, 2015 Allergan has successfully completed the acquisition of Kythera Biopharmaceuticals, a company focused on the discovery, development and commercialization of novel …See details»
Allergan to Acquire KYTHERA Biopharmaceuticals - Fierce Biotech
Jun 17, 2015 DUBLIN, Ireland and WESTLAKE VILLAGE, Calif., June 17, 2015 (GLOBE NEWSWIRE) -- Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and …See details»
KYTHERA Biopharmaceuticals, Inc. Asset Profile | Preqin
Founded in 2005, KYTHERA Biopharmaceuticals is a privately-held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of …See details»
Kythera Biopharmaceuticals, Inc. | Insights
Nov 14, 2019 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Kythera Biopharmaceuticals : Allergan Successfully Completes …
Oct 8, 2015 Allergan: Investors: Lisa DeFrancesco (862) 261-7152 Media: Mark Marmur (862) 261-7558 KYBELLA ® First FDA-Approved Non-Surgical Injection for Submental Fullness …See details»
KYTHERA Acquires Worldwide Rights to Clinical Compound and
Feb 10, 2015 Contact Data Investor Contact: Heather Rowe Director, Investor Relations Tel: (818) 587-4559 [email protected]See details»
Allergan to buy Kythera Biopharma for $2.1bn - Chemistry World
Pharma firm Allergan has agreed to buy Kythera Biopharmaceuticals in a $2.1 billion (£1.3 billion) deal.The acquisition follows the recent announcement that Kythera is to sell the only treatment ...See details»
Allergan Successfully Completes Kythera Acquisition; Adds Game …
DUBLIN, Oct. 1, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the acquisition …See details»
Emerging Drug Developer: Kythera Biopharmaceuticals
Kythera hopes to help shape the future of aesthetic medicine Keith Leonard is an optimist. Mulling over the prospects of Kythera Biopharmaceuticals after itsSee details»
Kythera Biopharmaceuticals Inc. - The New York Times
Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion. The deal will bolster the products of facial treatments at Allergan, the maker of Botox, by adding an injection for double chins ...See details»